These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23722932)

  • 21. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
    Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.
    Lundy SD; Zhu WZ; Regnier M; Laflamme MA
    Stem Cells Dev; 2013 Jul; 22(14):1991-2002. PubMed ID: 23461462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of hiPSC-Derived Cardiomyocytes.
    Horváth A; Lemoine MD; Löser A; Mannhardt I; Flenner F; Uzun AU; Neuber C; Breckwoldt K; Hansen A; Girdauskas E; Reichenspurner H; Willems S; Jost N; Wettwer E; Eschenhagen T; Christ T
    Stem Cell Reports; 2018 Mar; 10(3):822-833. PubMed ID: 29429959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
    Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
    Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
    Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
    Lickiss B; Hunker J; Bhagwan J; Linder P; Thomas U; Lotay H; Broadbent S; Dragicevic E; Stoelzle-Feix S; Turner J; Gossmann M
    J Pharmacol Toxicol Methods; 2024; 128():107529. PubMed ID: 38857637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.
    Bizy A; Guerrero-Serna G; Hu B; Ponce-Balbuena D; Willis BC; Zarzoso M; Ramirez RJ; Sener MF; Mundada LV; Klos M; Devaney EJ; Vikstrom KL; Herron TJ; Jalife J
    Stem Cell Res; 2013 Nov; 11(3):1335-47. PubMed ID: 24095945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
    Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
    J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental changes in electrophysiological characteristics of human-induced pluripotent stem cell-derived cardiomyocytes.
    Ben-Ari M; Naor S; Zeevi-Levin N; Schick R; Ben Jehuda R; Reiter I; Raveh A; Grijnevitch I; Barak O; Rosen MR; Weissman A; Binah O
    Heart Rhythm; 2016 Dec; 13(12):2379-2387. PubMed ID: 27639456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mathematical model of hiPSC cardiomyocytes electromechanics.
    Forouzandehmehr M; Koivumäki JT; Hyttinen J; Paci M
    Physiol Rep; 2021 Nov; 9(22):e15124. PubMed ID: 34825519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
    Wang L; Wada Y; Ballan N; Schmeckpeper J; Huang J; Rau CD; Wang Y; Gepstein L; Knollmann BC
    J Mol Cell Cardiol; 2021 Dec; 161():130-138. PubMed ID: 34400182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype.
    Pekkanen-Mattila M; Chapman H; Kerkelä E; Suuronen R; Skottman H; Koivisto AP; Aalto-Setälä K
    Exp Biol Med (Maywood); 2010 Apr; 235(4):522-30. PubMed ID: 20407085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.
    Luo XL; Zhang P; Liu X; Huang S; Rao SL; Ding Q; Yang HT
    Pflugers Arch; 2021 Jul; 473(7):991-1007. PubMed ID: 34031754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.
    Kernik DC; Morotti S; Wu H; Garg P; Duff HJ; Kurokawa J; Jalife J; Wu JC; Grandi E; Clancy CE
    J Physiol; 2019 Sep; 597(17):4533-4564. PubMed ID: 31278749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes.
    Chirikian O; Goodyer WR; Dzilic E; Serpooshan V; Buikema JW; McKeithan W; Wu H; Li G; Lee S; Merk M; Galdos F; Beck A; Ribeiro AJS; Paige S; Mercola M; Wu JC; Pruitt BL; Wu SM
    Sci Rep; 2021 Feb; 11(1):3026. PubMed ID: 33542270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.